<DOC>
	<DOCNO>NCT01675609</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy brimonidine tartrate 0.025 % ophthalmic solution use four time daily population adult geriatric subject</brief_summary>
	<brief_title>Study Evaluating Safety Efficacy Brimonidine Tartrate Ophthalmic Solution Adult Geriatric Subjects</brief_title>
	<detailed_description />
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Be least 40 year age Must normal ocular health Must history redness relief drop use desire use Must ocular/systemic health problem Must agree avoid disallow medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>